
TREATMENTS
Exploring new frontiers for the treatment of Spinal Cord Injury
TREATMENTS
Exploring new frontiers for the treatment of Spinal Cord Injury
17+ Years of using patented and proven stem cell treatments for Spinal Cord Injuries
Spinal Cord Injury (SCI) is a condition caused by damage or trauma to any region of the spine or the neural tissue, usually leading to a permanent loss of motor, sensory and autonomic function. SCI can be either ‘complete’ or ‘incomplete’ based on the functioning below the level of injury and patients can be classified as either ‘paraplegic’ or ‘quadriplegic’.
The conventional approach for Spinal Cord Injury patients includes rehabilitation therapies like physical therapy and occupational therapy. While these can help patients to better manage their daily living activities, they do not address the underlying issue ie. Spinal Cord Injury. Regenerative therapy using stem cells is increasingly becoming the preferred treatment modality for Spinal Cord Injury patients.
Stem cell treatment has the potential to repair and regenerate the damaged and non-functional cells in the spinal cord. Nutech MediWorld's Stem Cell Treatment helps to improve the function of the motor, sensory and autonomic systems in patients with Spinal Cord Injury. The result is improved mobility, better sensory functions and an enhanced quality of life.
At Nutech MediWorld, we assess the patients’ clinical condition using conventional tools like the ASIA classification, MRI, etc. to check their eligibility for stem cell treatment for Spinal Cord Injury.
We also conduct an additional round of thorough assessment using our proprietary NFS (Nutech Functional System) protocols wherein condition-based parameters are used for a finer assessment of the patient’s condition (and progress).
After evaluating the patient’s condition, a customized treatment protocol is created for the patient. This protocol is based on our proprietary stem cell platform, ReoStem®.
The patient’s progress is monitored on a weekly basis to further optimize treatment protocols depending on the patient’s response.
At the end of the treatment period, a complete assessment is done to track progress from when the patient came into where he/she has reached. If required, a follow-up treatment protocol is recommended.
At Nutech MediWorld, we follow an evidence-based, non-invasive, multi-disciplinary approach using Stem Cell Treatment & supporting therapies to improve the condition and overall quality of life for Spinal Cord Injury patients. Each treatment protocol comprises of the use of our patented technology, customized to suit the condition of the individual patient.
At Nutech Mediworld, we follow an evidence-based, non-invasive, multi-disciplinary approach using Stem Cell Treatment & supporting therapies to improve the condition and overall quality of life for Spinal Cord Injury Patients. Each treatment protocol comprises of the use of our patented technology, customized to suit the condition of the individual patient
At Nutech Mediworld, we assess the patients’ clinical condition using conventional tools like the ASIA classification, MRI etc. to check their eligibility for stem cell treatment for Spinal Cord Injury
We also conduct an additional round of thorough assessment using our proprietary NFS (Nutech Functional System) protocols wherein condition-based parameters are used for a finer assessment of the patient’s condition (and progress)
After evaluating the patient’s condition, a customized treatment protocol is created for the patient. This protocol is based on our proprietary stem cell platform, ReoStem
The patient’s progress is monitored on a weekly basis to further optimize treatment protocols depending on the patient’s response
At the end of the treatment period, a complete assessment is done to track progress from when the patient came into where he/she has reached. If required, a follow-up treatment protocol is recommended
We use SCT-N® and SCT-NX® products, based on a proprietary stem cell platform, ReoStem®, which comprises of a unique, replicable, clinical-stage technology for the generation and clinical application of allogenic stem cells.
Nutech Mediworld’s regenerative medicine products are universally applicable: they do not require tissue-matching or the co-administration of immunosuppressive drugs.
There is no evidence of teratoma generation or tumorigenesis associated with SCT-N® or SCT-NX® use in over 17 years of clinical practice across thousands of patients.
The unique cell culture methodology allows scalability of cell expansion and production.